← All organizations
Highest phase reached
Phase 4
Timeline
1990s
- Jan 1, 1998
Ironwood Pharmaceuticals— Founded
2010s
- Aug 18, 2017
allopurinol— Marketing Organization
- Aug 18, 2017
allopurinol— NDA Secondary Org
2020s
- Jun 16, 2023
VectivBio AG— Acquired
Drugs by trial phase (21 distinct, 61 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 1 via acquisition)
Phase 1 (8 own, 1 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Albuminuria
- Anemia, Sickle Cell
- Constipation
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diarrhea
- Digestive System Diseases
- Dyspepsia
- Esophageal Achalasia
- Esophagitis, Peptic
- Gastroesophageal Reflux
- Gastrointestinal Diseases
- Gastroparesis
- Gout
- Heart Failure
- Hypercholesterolemia
- Hypertension
- Irritable Bowel Syndrome
- Kidney Diseases
- Renal Insufficiency, Chronic
- Syndrome
Marketed drugs (2)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT05760313CollaboratorPhase 2Apr 27, 2023
- NCT05740007Lead sponsorPhase 2Mar 28, 2023
- NCT05740007Study directorPhase 2Mar 28, 2023
- NCT05652205CollaboratorPhase 3Dec 16, 2022
- NCT05362695Lead sponsorPhase 1May 17, 2022
- NCT05362695Study directorPhase 1May 17, 2022
- NCT05188261Lead sponsorPhase 1Jan 18, 2022
- NCT05188261Study directorPhase 1Jan 18, 2022
- NCT04166058CollaboratorPhase 3Nov 19, 2019
- NCT04110145CollaboratorPhase 2Sep 30, 2019
- NCT04026113CollaboratorPhase 3Aug 14, 2019
- NCT03931785Lead sponsorPhase 2May 1, 2019
- NCT03931785Study chairPhase 2May 1, 2019
- NCT03856970Lead sponsorPhase 1Mar 11, 2019
- NCT03856970Study directorPhase 1Mar 11, 2019
Details
- Founded
- Cambridge, MA, US Jan 1, 1998
- Last known activity
- Apr 27, 2023
Notes
--- Pre-folding founded info: 2008-01-01 Cambridge MA US https://en.wikipedia.org/wiki/Ironwood_Pharmaceuticals ---